1 Fuentes JJ,Pritchard MA,Planas AM,et al.A new human gene from the down syndrome critical region encodes a proline-rich protein highly expressed in fetal brain and,heart[J].Hum Mol Genet,1995,4(10):1935.
2 Patel A,Yamashita N,Ascao M,et al.RCAN1 links impaired neurotrophin trafficking to aberrant development of the sympathetic nervous system in down syndrome[J].Nat Commun,2015,6:10119.
3 Wong H,Levenga J,Cain P,et al.RCAN1 overexpression promotes age-dependent mitochondrial dysregulation related to neurodegeneration in Alzheimer′s disease[J].Acta Neuropathol,2015,130(6):829-843.
4 Torac E,Gaman L,Atanasiu V.The regulator of calcineurin(RCAN1)an important factor involved in atherosclerosis and cardiovascular diseases development[J].J Med Life,2014,7(4):481-487.
5 Peiris H,Raghupathi R,Jessup CF,et al.Increased expression of the glucose-responsive gene,RCAN1,causes hypoinsulinemia,β-cell dysfunction,and diabetes[J].Endocrinology,2012,153(11):5212-5221.
6 Ma N,Shen W,Pang H,et al.The effect of RCAN1 on the biological behaviors of small cell lung cancer[J].Tumour Biol,2017,39(6):1010428317700405.
7 马宁强,陈连宏,张贺龙,等.内源性CaN蛋白抑制剂RCAN1在肿瘤中的作用[J].现代肿瘤医学,2011,19(9):1866-1869.
8 Lu M,Zheng L,Han B,et al.Rest regulates dyrk1a transcription in a negative feedback loop[J].J Biol Chem,2011,286(12):10755-10763.
9 Xing L,Salas M,Zhang H,et al.Creation and characterization of BAC-transgenic mice with physiological overexpression of epitope-tagged RCAN1,(DSCR1)[J].Mammalian Genome,2013,24(1/2):30-43.
10 Kim SS,Jang SA,Su RS.CREB-mediated Bcl-2 expression contributes to RCAN1 protection from hydrogen peroxide-induced neuronal death[J].J Cell Biochem,2013,114(5):1115-1123.
11 Taromi S,Kayser G,Catusse J,et al.CXCR4 antagonists suppress small cell lung cancer progression[J].Oncotarget,2016,7(51):85185.
12 Pang H,Ma N,Jiao M,et al.The biological effects of dickkopf1 on small cell lung cancer cells and bone metastasis[J].Oncol Res,2017,25(1):35-42.
13 Miki T,Yano S,Hanibuchi M,et al.Bone metastasis model with multiorgan dissemination of human small-cell lung cancer(SBC-5)cells in natural killer cell-depleted SCID mice[J].Oncol Res,2000,12(5):209-217.
14 Stathatos N,Bourdeau I,Espinosa AV,et al.KiSS-1/G protein-coupled receptor 54 metastasis suppressor pathway increases myocyte-enriched calcineurin interacting protein 1 expression and chronically inhibits calcineurin activity[J].J Clin Endocrinol Metab,2005,90(9):5432-5440.
15 Wang C,Saji M,Justiniano SE,et al.RCAN1-4 is a thyroid cancer growth and metastasis suppressor[J].JCI Insight,2017,2(5):e90651.
16 Santos NRD,Ghezzo MN,Silva RCD,et al.NF-κB in T-cell acute lymphoblastic leukemia:oncogenic functions in leukemic and in microenvironmental cells[J].Cancers(Basel),2010,2(4):1838-1860.
17 Safa M,Tavasoli B,Manafi R,et al.Indole-3-carbinol suppresses NF-κB activity and stimulates the p53 pathway in pre-B acute lymphoblastic leukemia cells.[J].Tumour Biol,2015,36(5):3919-3930.
18 Savva CG,Totokotsopoulos S,Nicolaou KC,et al.Selective activation of TNFR1 and NF-κB inhibition by a novel biyouyanagin analogue promotes apoptosis in acute leukemia cells[J].BMC Cancer,2016,16(1):279.
19 Savl H,Akkoyunlu RU,Çine N,et al.Deregulated levels of the NF-κB1,NF-κB2,and rel genes in ukrainian patients with leukemia and lymphoma in the post-chernobyl period[J].Turk J Haematol,2016,33(1):8-14.
20 Bosman MC,Schuringa JJ,Vellenga E.Constitutive NF-κB activation in AML:Causes and treatment strategies.[J].Crit Rev Oncol Hematol,2016,98:35-44.
21 Kazuaki N,Yujiro I,Toshiyuki M.RCAN1 is an important mediator of glucocorticoid-induced apoptosis in human leukiemic cells[J].PLoS One,2012,7(11):e49926.
22 Jin H,Wang C,Jin G,et al.Regulator of calcineurin 1 Gene isoform 4,downregulated in hepatocellular carcinoma,prevents proliferation,migration,and invasive activity of cancer cells and growth of orthotopic tumors by inhibiting nuclear translocation of NFAT1[J].Gastroenterology,2017[Epub ahead of print].
23 Zucman-Rossi J,Villanueva A,Nault JC,et al.Genetic landscape and biomarkers of hepatocellular carcinoma[J].Gastroenterology,2015,149(5):1226-1239.
24 Kawahara T,Kashiwagi E,Ide H,et al.Cyclosporine A and tacrolimus inhibit bladder cancer growth through down-regulation of NFATc1[J].Oncotarget,2015,6(3):1582.
25 Kepes JJ,Rubinstein LJ.Malignant gliomas with heavily lipidized(foamy)tumor cells:a report of three cases with immunoperoxidase study.[J].Cancer,2015,47(10):2451-2459.
26 Vaccaro V,Fabi A,Vidiri A,et al.Activity and safety of bevacizumab plus fotemustine for recurrent malignant gliomas.[J].Biomed Res Int,2014,2014(1):351252.
27 Tabatabaei P,Visse E,Bergström P,et al.Radiotherapy induces an immediate inflammatory reaction in malignant glioma:a clinical microdialysis study[J].J Neurooncol,2017,131(1):83-92.
28 Muroski ME,Morshed RA,Cheng Y,et al.Controlled payload release by magnetic field triggered neural stem cell destruction for malignant glioma treatment[J].PLoS One,2016,11(1):e0145129.
29 Mccowage GB,Friedman HS,Moghrabi A,et al.Activity of high‐dose cyclophosphamide in the treatment of childhood malignant gliomas[J].Med Pediatr Oncol,2015,30(2):75-80.
30 Yili W,Weihong S.Regulation of RCAN1 translation and its role in oxidative stress-induced apoptosis[J].FASEB J,2013,27(1):208.
31 Chen X,Hu Y,Wang S,et al.The regulator of calcineurin 1(RCAN1)inhibits nuclear factor kappaB signaling pathway and suppresses human malignant glioma cells growth[J].Oncotarget,2017,8(7):12003-12012.
32 Genot JY,Krulik M,Poisson M,et al.Two cases of acute leukemia following treatment of malignant glioma[J].Cancer,2015,52(2):222-226.
33 Byron SA,Loch DC,Pollock PM.Fibroblast growth factor receptor inhibition synergizes with Paclitaxel and Doxorubicin in endometrial cancer cells[J].Int J Gynecol Cancer,2012,22(9):1517-1526.
34 Sales KJ,Grant V,Cook IH,et al.Interleukin-11 in endometrial adenocarcinoma is regulated by prostaglandin F2alpha-F-prostanoid receptor interaction via the calcium-calcineurin-nuclear factor of activated T cells pathway and negatively regulated by the regulator of calcineurin-1[J].Am J Pathol,2010,176(1):435-445. |
